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RESEARCH ARTICLE Open Access
Prevention and reversal of selenite-induced
cataracts by N-acetylcysteine amide in
Wistar rats
Yasaswi Maddirala1†, Shakila Tobwala1†, Humeyra Karacal2 and Nuran Ercal1*
Abstract
Background: The present study sought to evaluate the efficacy of N-acetylcysteine amide (NACA) eye drops in
reversing the cataract formation induced by sodium selenite in male Wistar rat pups.
Methods: Forty male Wistar rat pups were randomly divided into a control group, an N-acetylcysteine amide-only
group, a sodium selenite-induced cataract group, and a NACA-treated sodium selenite-induced cataract group.
Sodium selenite was injected intraperitoneally on postpartum day 10, whereas N-acetylcysteine amide was injected
intraperitoneally on postpartum days 9, 11, and 13 in the respective groups. Cataracts were evaluated at the end of
week 2 (postpartum day 14) when the rat pups opened their eyes. N-acetylcysteine amide eye drops were administered
beginning on week 3 until the end of week 4 (postpartum days 15 to 30), and the rats were sacrificed at the end of week
4. Lenses were isolated and examined for oxidative stress parameters such as glutathione, lipid peroxidation, and calcium
levels along with the glutathione reductase and thioltransferase enzyme activities. Casein zymography and Western blot
of m-calpain were performed using the water soluble fraction of lens proteins.
Results: Morphological examination of the lenses in the NACA-treated group indicated that NACA was able to reverse
the cataract grade. In addition, glutathione level, thioltransferase activity, m-calpain activity, and m-calpain level (as assessed
by Western blot) were all significantly higher in the NACA-treated group than in the sodium selenite-induced cataract group.
Furthermore, sodium selenite- injected rat pups had significantly higher levels of malondialdehyde, glutathione reductase
enzyme activity, and calcium levels, which were reduced to control levels upon treatment with NACA.
Conclusions: The data suggest that NACA has the potential to significantly improve vision and decrease the burden of
cataract-related loss of function. Prevention and reversal of cataract formation could have a global impact. Development
of pharmacological agents like NACA may eventually prevent cataract formation in high-risk populations and may prevent
progression of early-stage cataracts. This brings a paradigm shift from expensive surgical treatment of cataracts to relatively
inexpensive prevention of vision loss.
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Background
Cataract is a progressive loss of transparency of the lens
that affects vision. It is the most common cause of
curable blindness, accounting for more than 50% of
cases worldwide [1]. Most cataracts are age-related and,
according to the National Eye Institute (NEI), by age 80,
more than half of all Americans either have a cataract or
have had cataract surgery. The NEI and Prevent Blind-
ness America estimate that more than 22 million people
in the U.S. live with cataracts and, by 2020, this may
exceed 30 million. Although cataract is not associated
with signs such as pain or redness in the eye, it is still
characterized by symptoms such as blurry vision, double
vision, glare of light, and fading of colors. Presently, the
only effective treatment option is the surgical removal of
the affected lens and replacement with an artificial lens.
However, the cost of surgery and need for highly trained
personnel to perform ocular surgery limit restoration of
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vision in certain parts of the world. Unfortunately, the
majority of people with vision impairment due to cata-
racts live in developing countries where access to
surgery is limited [2]. Hence, there is an immediate neces-
sity for prevention and non-invasive treatment of cataracts.
The pathogenesis of cataracts is multifactorial, involv-
ing mechanisms that are not fully understood, with
oxidative stress being the foremost cause in initiating
cataract formation [3–9]. Oxidative stress implies an
imbalance between the rate of oxidant production and
the rate of detoxification, with the rate of production
being significantly higher compared to that of detoxifica-
tion by antioxidants [10]. An organism counteracts this
condition with its natural antioxidant defense systems,
but with age, oxidants accumulate while antioxidant
defenses gradually diminish, which is likely the most im-
portant mechanism in age-related cataract formation.
Furthermore, Shearer [11] proposed the involvement of
oxidative stress in selenite-induced cataract and the
sequence of events leading to cataract formation. It was
hypothesized that the oxidative damage caused by selen-
ite possibly involves oxidation of critical sulfhydryl
groups on calcium ATPase or ion channels. [11] This
may lead to altered metabolism in lens epithelium and
loss of calcium ATPase activity and, hence, an accumula-
tion of calcium in the nucleus of the lens, which could
activate m-calpain. Activation of m-calpain initiates the
proteolysis of β-crystallins, leading to the insolubilization
of both proteolyzed β- and α-crystallins, co-precipitation
of γ-crystallins, and ultimately the formation of
cataracts. Since oxidative stress is implicated in cataract
formation, application of an antioxidant capable of suc-
cessfully penetrating the lens tissue represents a logical
approach to counteract oxidation-related cataractogen-
esis. Several compounds with antioxidant properties
have been reported to prevent selenite-induced
cataracts, such as resveratrol [12], saffron [13], ellagic
acid [14], garlic [15], melatonin [16], drevogenin D [17],
caffeine [18], ebselen [19], lycopene in vivo [20],
N-acetyl-L-carnitine in vitro and in vivo [21–23], and
Ocimum sanctum in vivo and ex vivo [24]. In fact,
N-acetylcysteine (NAC), a glutathione (GSH) prodrug,
has previously been tried in selenite-induced cataracts in
vivo [25] and was shown to prevent oxidative damage to
the lens, slowing down cataractogenesis.
Use of antioxidants in treating or preventing oxidative
stress-related disorders is becoming more popular, with
thiol antioxidants, such as GSH, cysteine, and NAC,
showing some protection [26–28]. However, the negative
charge on the NAC molecule at physiological pH
renders it less able to permeate cell membranes. This re-
sults in the use of higher doses and extended treatment
schedules. In contrast, N-acetylcysteine amide (NACA),
an analog of NAC, has been shown to be more effective
than NAC, owing to its neutral amide group, which
increases its lipophilicity and, consequently, its penetra-
tion into cell membranes. This has been verified in pre-
vious studies, as well as its ability to chelate Cu2+,
scavenge free-radicals, and protect against oxidative
stress [29–36]. Our lab has demonstrated NACA’s
improved antioxidant ability compared to that of NAC
[33, 37]. Furthermore, NACA is effective at lower
concentrations than NAC, which helps to prevent the
various adverse effects that are associated with adminis-
tration of higher doses of NAC [26, 31, 38–40].
Based on these results, the primary objective of this
study was to assess the ability of NACA to prevent and/
or reverse selenite-induced cataract formation in Wistar
rats. We demonstrated that NACA, when injected intra-
peritoneally on postpartum days 9, 11, and 13 helped to
prevent dense nuclear cataract formation [41, 42].
Continuous NACA administration (from postpartum
day 15 to 30) as an eye drop formulation reversed the
density of the cataract. Our results demonstrate that
NACA administration bolstered antioxidant defenses of
selenite-dosed animals by replenishing GSH, inhibiting
lipid peroxidation, preventing accumulation of calcium,
thereby preventing activation of m-calpain and eventu-
ally preserving the lens crystallin proteins. Therefore,
NACA shows promise as a candidate for development
into a drug-based cataract treatment.
Methods
Materials
Sodium selenite (Na2SeO3, Cat no: 214,485, ≥99% pure)
and N-(1-pyrenyl) maleimide (NPM, Cat no: P7908,
≥98.5% pure) were purchased from Sigma-Aldrich (St.
Louis, MO, USA). N-acetylcysteine amide (NACA,
≥99.9% pure) was provided by Dr. Glenn Goldstein
(David Pharmaceuticals, New York, NY, USA). Casein
zymogram gels (12% Ready Gel, Cat no: 161–1168) were
purchased from Bio-Rad (Hercules, CA, USA). Rabbit
m-calpain Antibody (Cat no: 2539S), GAPDH Rabbit
mAb (Cat no: 2118S), and Anti-rabbit IgG, HRP-linked
Antibody (Cat no: 7074S) were purchased from Cell
Signaling Technology (Beverly, MA, USA). All other
chemicals were purchased from Sigma-Aldrich, unless
stated otherwise.
Animal study design
Lactating female Wistar rats with 40 2-day-old male
pups were purchased from the breeding facility at
Charles River and were housed in a temperature- and
humidity-controlled (~22 °C and ~55%) animal facility,
with a 12-h light and dark cycle. The animals had unlim-
ited access to rodent chow and water and were utilized
after a week of acclimation. All animal procedures con-
formed to the ARVO Statement for the Use of Animals
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in Ophthalmic and Vision Research and by the Animal
Care and Use Protocol Review Committee at the
Missouri University of Science and Technology. The rats
were divided into four groups, (1) control, (2) NACA,
(3) Na2SeO3, and (4) NACA + Na2SeO3, such that each
group had one lactating female rat with 10 male pups.
All rat pups in the NACA and NACA + Na2SeO3 groups
received an intraperitoneal injection of NACA (250 mg/kg
bodyweight) once a day on postpartum days 9, 11, and 13
to investigate the preventive effect of NACA on selenite-
induced cataracts, whereas the control and Na2SeO3
groups received an intraperitoneal injection of phosphate
buffer (pH 7.4). On postpartum day 10, all rat pups in the
Na2SeO3 and NACA + Na2SeO3 groups received an intra-
peritoneal injection of sodium selenite (19 μmol/kg body
weight), whereas the control and NACA groups received
equivalent volumes of phosphate buffer (pH 7.4). One
percent NACA eye drops, prepared in phosphate buffer
(pH 7.4), were started from postpartum day 15 (the day
that the rat pups opened their eyes) and continued
through postpartum day 30 to check for the reversal effect
of NACA on the grade of cataracts in the NACA +
Na2SeO3 group (Table 1). Cataracts were graded after
examination with a slit lamp microscope on postpartum
day 15 before starting the eye drops and on the last day
(postpartum day 30) before sacrificing the pups. All rats
were anesthetized 2–3 h after administration of the last
NACA or buffer eye drop by intraperitoneal injection of
ketamine (80 mg/kg) and xylazine (15 mg/kg). The mass
of each rat pup was measured at the beginning and the
end of the study. Lenses were removed immediately after
euthanasia, and promptly placed on dry ice. Samples were
stored at a temperature of −80 °C for further analysis.
Morphological examination of rat eyes
Morphological examination of rat eyes was performed
similarly to the procedure described in Carey et al. [30].
One hour prior to examination, a drop of both 2.5%
phenylephrine hydrochloride and 1% tropicamide oph-
thalmic solutions were instilled in each eye to initiate
mydriasis. Examination was performed with a slit lamp
microscope at 10× magnification. Representative photo-
graphs were taken of each lens for assessment by a
certified ophthalmologist. Cataracts were graded accord-
ing to the following scale: clear lens, grade 0; lens with
slight opacity, grade 1; lens with partial nuclear opacity,
grade 2; lens with dense nuclear opacity, grade 3.
Determination of GSH levels
GSH levels in lens tissues were measured according to
an HPLC method developed within our laboratory and
described previously [30, 43]. Briefly, each lens was ho-
mogenized in a serine borate buffer (pH 7.8), followed
by centrifugation at 5000 × g for 10 min at 4 °C. The
resulting supernatant was removed and diluted. A 50 μL
aliquot of this diluted supernatant was then added to
200 μL of nanopure water. To each sample, 750 μL of
1 mM NPM in acetonitrile was added. The derivatiza-
tion reaction was allowed to proceed at room for 5 min,
after which time 10 μL of 2 N HCl was added to quench
the reaction. Each sample was transferred to an HPLC
vial through a 0.45 μm pore filter. HPLC separation and
analysis were performed on a Finnigan Surveyor system
(Thermo Scientific), which included an Auto Sampler
Plus, LC Pump Plus, FL plus Detector, and a 250 × 4.6 mm
Reliasil ODS-1 C18 column with 5 μm packing material
(Orochem Technologies Inc., Naperville, IL, USA). This
system was used for all subsequent HPLC analyses
described herein. The mobile phase was composed of
acetonitrile and nanopure water (70:30 v/v ACN: H2O)
with 1 mL/L acetic acid and 1 mL/L phosphoric acid added
to the water to adjust the pH to 2.5. An isocratic method
was used, with a flow rate of 1 mL/min. Excitation and
emission wavelengths for NPM derivatives were set at 330
and 376 nm, respectively.
Determination of total glutathione and glutathione
disulfide (GSSG) levels
Total glutathione content was determined by reverse
phase HPLC, and lens homogenate was prepared and
diluted as described above for GSH analysis. 50 μL of
diluted supernatant was then added to 60 μL of NADPH
(2 mg/mL) in nanopure water. To each sample, 20 μL of
glutathione reductase (1 unit/mL) was added, followed
by 5 min of incubation at room temperature. After incu-
bation, 120 μL of nanopure water was added, and then
750 μL of 1.0 mM NPM was added to derivatize. After
5 min at room temperature, the reaction was quenched
by the addition of 10 μL of 2 N HCl. Filtration and injec-
tion were performed as described for HPLC analysis of
GSH. Data from the original GSH levels and the total
GSH levels in each sample were subsequently used to
calculate the levels of GSSG present in each sample.
Determination of malondialdehyde (MDA)
MDA determination was performed following the method
described by Draper [44] and used in our previous
Table 1 Treatment groups studied
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cataract studies [30]. First, 350 μL of the lens hom-
ogenate was added to 550 μL of 5% TCA and 100 μL
of 500 ppm butylated hydroxytoluene in methanol.
Samples were heated in a boiling water bath for
30 min, cooled in an ice water bath, and then centri-
fuged. Equal portions of the supernatant and a satu-
rated solution of thiobarbituric acid were mixed, then
heated and cooled in the same manner. 500 μL of
each sample mixture was then added to 1 mL of
n-butanol, vortexed for 5 min, and then centrifuged.
The organic phase was passed through a 0.45 μm fil-
ter and injected into the HPLC system described
above. However, the mobile phase for MDA analysis
consisted of 69.4% sodium phosphate buffer, 30%
acetonitrile, and 0.6% tetrahydrofuran (by volume).
Excitation and emission wavelengths were set to
515 nm and 550 nm, respectively.
Determination of glutathione reductase (GR) activity
Glutathione reductase (GR) catalyzes the NADPH-
dependent reduction of GSSG to GSH. A commercially
available kit (OxisResearch, Portland, OR, USA) was
used to perform a spectrophotometric assay that moni-
tors the decrease in absorbance at 340 nm resulting
from the oxidation of NADPH to NADP+. The rate of
decrease in absorbance is directly proportional to the
GR activity in the samples, which were prepared accord-
ing to the manufacturer’s instructions.
Determination of thioltransferase (Ttase) activity
The thioltransferase activity (Ttase) was determined by
the method of Wang [45]. Briefly, 100 μL of lens
homogenate was added to 800 μL of solution with 0.1 M
phosphate buffer (pH 7.5), 0.2 mM NADPH, 0.5 mM
GSH, and 0.4 units of glutathione reductase. Each
sample was centrifuged, followed by addition of 100 μL
of 20 mM hydroxyethyl disulfide. Absorbance at 340 nm
was measured for 2 min. Blanks were prepared without
hydroxyethyl disulfide.
Determination of calcium concentration in the lens
The lenses from all groups were analyzed to deter-
mine the Ca2+ concentration, as described by
Elanchezhian [21]. Briefly, lenses were placed in acid-
washed, tared glass vials and heated at 100 °C for
20 h, after which time the dry weights were recorded.
Concentrated HCl (0.2 mL) was added to digest the
lenses overnight and diluted to 1 mL with deionized
water. The samples were then centrifuged at 10,000 ×
g for 10 min to remove insoluble materials. The
supernatant fractions were collected to measure the
calcium concentration using an atomic absorption
spectrophotometer (model Spectra AA-3100, Perkin
Elmer), operated with a slit width of 0.5 nm and
wavelength set at 422.7 nm. Standards were prepared
from CaCO3 and deionized water.
Casein zymography
Casein zymography was performed using the method of
Raser [46]. Casein zymogram gels (12% polyacrylamide)
were purchased from Bio-Rad. Protein concentration
was determined using the Bio-Rad DC Protein Assay
with bovine serum albumin as a standard. Zymogram
sample buffer was added to an amount of supernatant
containing 50 μg of protein, so that final volume was
30 μL. The casein gels were prerun at 100 V for 15 min,
4 °C, with a running buffer containing 25 mM Tris-HCl,
0.05% MCE, 192 mM glycine, and 1 mM EDTA (pH 8.3)
before samples were loaded into the wells. 25 μl of each
sample were loaded and electrophoresed at 100 V (con-
stant) for 2 h at 4 °C in a running buffer. The gels were
then incubated in a calcium buffer (20 mM Tris-HCl,
10 mM DTT, 2 mM calcium, pH 7.4) overnight at room
temperature with slow shaking. The gels were then
stained by Coomassie Brilliant Blue and destained;
achromatic bands of caseinolysis appeared white against
a stained background.
Preparation of water –soluble lens proteins
Four de-capsulated lenses from each group were homog-
enized in 600 μL of lysis buffer (20 mM Tris-HCl
(pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA,
1% Triton, 2.5 mM sodium pyrophosphate, 1 mM
β-glycerophosphate, 1 mM Na3VO4, 1 μg/mL leupeptin,
and 2 mM PMSF; Cell Signaling Technology, Inc.,
Danvers, MA, USA) using a glass Dounce homogenizer.
The homogenates were centrifuged at 10,000 × g for
15 min at 4 °C, and the recovered supernatants were
designated as the water-soluble fraction.
Western blot of m-calpain
The water-soluble fraction of lens proteins was used to
determine m-calpain levels by Western blot as described
by Tobwala et al. [47]. Briefly, 75 μg of soluble lens
proteins were resolved by electrophoresis on 10% Mini--
Protean TGX gels (100 V, 2 h) in a running buffer con-
taining 25 mM Tris-HCl, 192 mM glycine, 0.05% MCE,
and 0.1% SDS (pH 8.3). The samples were transferred to
PVDF membranes by an iBlot® Gel Transfer Device (Life
Technologies, Grand Island, NY, USA), followed by the
addition of a blocking reagent (blok-CH Chemilumines-
cent Blocker, Millipore, Billerica, MA, USA). Membranes
were immunoblotted by using the SNAP i.d. 2.0 Protein
Detection System (Millipore) with primary antibodies
for m-calpain and GAPDH in 1:750 and 1:1000 dilutions
respectively. Subsequently, the membrane was incubated
in the respective secondary antibody (1:1000) for 10 min
at room temperature. Final visualization was carried out
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with the enhanced chemiluminescence kit (Cell Signal-
ing Technology, Inc., Danvers, MA, USA). The intensity
of protein bands was determined by normalizing against
the intensity of GAPDH band. The relative band inten-
sity ratio of the treated group over the control group
was calculated.
Determination of protein
The Bradford method was used to quantify protein levels
in the lens homogenates [48], except for casein zymogra-
phy and the Western blot, where the Bio-Rad DC pro-
tein assay was used. This was because the lysis buffer
(mentioned in the “Preparation of water-soluble lens
proteins” section) contained 1% detergent which would
interfere with the results of the Bradford assay. Bovine
serum albumin was used as the protein standard.
Statistical analysis
All reported values were represented as the mean ± S.E.
of quadruplicates. Statistical analysis was performed
using GraphPad Prism software (GraphPad, San Diego,
CA, USA). Statistical significance was ascertained by
one-way analysis of variance, followed by Tukey’s mul-
tiple comparison tests. Values of p < 0.05 were consid-
ered significant.
Results
Effects of Na2SeO3 and NACA on cataract formation in the
lens
Intraperitoneal injection of Na2SeO3 (19 μmol/kg) on
postpartum day 10 was sufficient to induce cataract
formation, which was visible by the time the rat pups
opened their eyes. Inspection of the rat pups’ eyes with a
slit lamp microscope confirmed that all animals injected
only with Na2SeO3 developed cataracts: two out of ten
(20%) developed grade 2 cataracts and the remaining
eight out of ten (80%) developed grade 3 cataracts. In
comparison, NACA intraperitoneal injections decreased
the severity of cataract formation; eight rats out of ten
(80%) developed grade 2 cataracts, while one rat formed
grade 1 cataracts, and one rat did not develop any cata-
racts (grade 0). These results indicated that NACA was
successful in preventing cataract formation. By the end
of week 4, there was no change in the grades of the cata-
racts in the Na2SeO3-injected rat pups (eight out of ten
(80%) rats had grade 3 cataracts, and two rats had grade
2 cataracts). However, treatment with NACA eye drops
decreased the severity of cataract formation, where five
rats out of the ten (50%) had grade 2 cataracts, four rats
had grade 1 cataracts, and one rat had no cataract (grade
0). The grading of the lens in all of the groups is
tabulated in Table 2, and the slit-lamp pictures of
representative lenticular opacities observed for each
group are shown in Fig. 1.
Effects of NACA on GSH and GSSG levels in the lens
GSH levels in lenses from the Na2SeO3 group were
found to be significantly (p < 0.05) lower than those of
the lenses from the control and NACA groups. However,
treatment with NACA in the NACA + Na2SeO3 group
(Fig. 2a) significantly (p < 0.05) increased GSH levels
compared to the Na2SeO3 group.
GSSG levels in the lenses from the Na2SeO3 group
were found to be significantly (p < 0.05) higher than
those in the lenses from the control group. However,
NACA treatment (NACA + Na2SeO3 group) was not
able to reduce GSSG levels back to the control (Fig. 2b).
The ratio of GSH and GSSG in the lenses from the
Na2SeO3 group was found to be significantly lower
(p < 0.05) than in the lenses from the control group,
whereas the GSH/GSSG ratio in the NACA treatment
group (NACA + Na2SeO3) was close to the control
group lenses (Fig. 2c).
Effects of NACA on MDA levels
MDA levels in the lenses from the Na2SeO3 group
were found to be significantly (p < 0.05) higher than
those in the control group lenses. However, MDA
levels in NACA-treated animals were significantly
reduced (p < 0.05) and were similar to those in the
control group (Fig. 3).
Effects of NACA on GR and Ttase activities
The GR activity in lenses from the Na2SeO3 group
was found to be significantly (p < 0.05) higher than
that of the control, NACA, and NACA + Na2SeO3
groups.
The Ttase activity in the lenses of the Na2SeO3 group
was found to be significantly (p < 0.05) lower than that
of the control group lenses. However, Ttase activity in
the NACA treatment group (NACA + Na2SeO3) was
close to that of the control group (Table 3).
Table 2 Classification of the degree of cataract formation in rat







0 1 2 3 0 1 2 3
Sham-treated control
group
10 0 0 0 10 0 0 0
NACA group 10 0 0 0 10 0 0 0
Na2SeO3 group 0 0 2 8 0 0 2 8
NACA + Na2SeO3
group
1 1 8 0 1 4 5 0
Morphological examination of rat lenses at week 2 and week 4. Dense cataract
formation was prevented by NACA injection in the NACA + Na2SeO3 group at
the end of week 2 when the rats opened their eyes. Continuation of NACA eye
drops until the end of week 4 decreased the number of rats with grade 2
cataracts, reversing them to grade 1.
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Effects of Na2SeO3 and NACA on calcium levels in the
lens
Lenses from rat pups in the Na2SeO3 group showed
significantly (p < 0.05) higher levels of calcium than the
lenses in the control and NACA-only groups. However,
treatment with NACA showed a significant (p < 0.05)
reduction in the levels of calcium compared to those of
the Na2SeO3 group, with the levels becoming nearly the
same as those of the control (Fig. 4).
Effects of Na2SeO3 and NACA on casein zymography
Elevated calcium levels in Na2SeO3-treated animals
prompted the comparison of m-calpain activation.
Casein zymography was performed, wherein calcium-
activated calpain-mediated lysis of casein on the gel
was measured. The casein zymogram showed a less
intense band of m-calpain in the lenses of the
Na2SeO3 group. However, the intensity of the band in
the NACA-treated group was close to that of the
control group (Fig. 5a).
Effects of Na2SeO3 and NACA on the Western blot of
m-calpain
To support our results of casein zymography, Western
blot analysis of m-calpain protein was performed in the
soluble protein fractions of lenses. A less intense band of
m-calpain protein was observed in the lenses of the
Na2SeO3 group compared to the control group lenses.
However, lenses in the NACA + Na2SeO3 group showed
a more intense band when compared with the Na2SeO3
group (Fig. 5b, c).
Discussion
Cataract is the leading cause of blindness worldwide,
and surgical replacement of the opacified lens with an
artificial lens is currently the only way to remedy vision
loss. Although cataract surgery is considered to be very
successful in terms of visual outcome, the cost, need for
trained personnel, and postsurgical complications limit
the worldwide availability and accessibility to this
procedure. Hence, development of alternatives to surgical
intervention is warranted [49].
Oxidative stress is an imbalance between the rate of
oxidant production and degradation [50]. Substantial
supporting evidence suggests that reactive oxygen
species (ROS) and oxidative damage are involved in the
development of cataracts [51, 52]. Cataract formation
has a multifactorial etiology. Oxidative stress, resulting
in the depletion of antioxidant defense systems in the
lens, is considered to be a major factor in the formation
of cataracts. Lens transparency is dependent on the
preservation of a favorable redox balance, which is, in
part, maintained by its high GSH content [53–55]. De-
creased levels of GSH in the lens can lead to free radical
accumulation, resulting in lipid peroxidation and de-
creased antioxidant enzyme activity [56, 57], all of which
lead to cataract development. Therefore, an alternative
method to prevent or treat cataracts would be the use of
Fig. 1 Slit lamp images of eyes. These pictures were taken at week 4 (1 day before sacrifice). A representative picture of the lenses observed for
each group is shown. a: Lenses from control group were found to be clear with no detectable cataracts; b: Lenses from NACA group exhibited
similar results as that of control, with no detectable cataracts; c: Lenses from Na2SeO3 group exhibited dense nuclear cataracts (80%); d: Lenses
from NACA + Na2SeO3 group exhibited lower grade of cataracts
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a thiol antioxidant. Based on this, we have investigated
the effects of a novel thiol antioxidant, NACA, in
selenite-induced cataracts. Results from morphological
observation indicate that NACA was able to prevent and
reverse the formation of cataracts in the NACA + Na2SeO3
group (Table 2).
As discussed earlier, GSH is the most important anti-
oxidant in the lens; it is the first line of defense against
oxidative stress [58]. Our results show a significant
decrease in GSH levels in the lenses of the Na2SeO3
group (Fig. 2a) when compared to those of the control
group indicating oxidative stress. In addition to a
decrease in GSH, increase in intracellular GSSG (Fig. 2b)
levels were observed in the lenses of the Na2SeO3 group.
In addition, the GSH/GSSG ratio, an indicator of the
overall antioxidative capacity of a cell, was decreased in
the lenses of the Na2SeO3 group. Treatment with NACA
significantly increased the GSH levels in the NACA-
treated group. This suggests that NACA was able to
prevent oxidative stress by restoring GSH levels. This
is likely achieved through several processes: supplying
cysteine for GSH biosynthesis, reducing extracellular
cystine to cysteine [59], and converting GSSG to GSH
by non-enzymatic thiol disulfide exchange [31]. Our
results are in agreement with previous studies that
reported a decrease in GSH levels upon Na2SeO3
treatment in animal models [14, 19, 60–64].
However, significant improvement in the GSH/GSSG
ratio was not observed in the NACA + Na2SeO3 group
(Fig. 2c). Furthermore, changes in the levels of GSH and
GSSG were seen to affect the activity of GR. This
enzyme regenerates GSH from its oxidized form and is
imperative to GSH homeostasis. Increased activity of GR
in the lenses of the Na2SeO3 group could be attributed
BA
C
Fig. 2 Effect of NACA on (A) GSH, (B) GSSG, and (C) GSH/GSSG in lenses of rat pups injected with Na2SeO3. a Treatment with NACA increased the
GSH levels significantly when compared with the Na2SeO3 group. b Treatment with NACA didn’t show a significant decrease in GSSG levels. c Treatment
with NACA increased the GSH/GSSG ratio, but is neither significantly different from control nor Na2SeO3 group lenses. Statistical Analysis was performed by
one-way analysis of variance, followed by Tukey’s multiple comparison tests. *p < 0.05 compared to the control group and #p < 0.05 compared to the
Na2SeO3 group. Values are reported as mean (n = 4) ± S.E
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to the activation of the lens antioxidant defense network
against a change in the redox status. However, this
increase in activity of GR was not sufficient to convert
all of the GSSG to GSH and resulted in a high level of
GSSG leading to a lower GSH/GSSG ratio. Furthermore,
NACA treatment increased the levels of GSH and
restored GR activity (Table 3).
Lipid peroxidation has been associated with cataract
formation [65–67]. Polyunsaturated fatty acids are
susceptible to free radical attack, initiating a chain reac-
tion that terminates in the formation of stable by-
products, such as malondialdehyde (MDA), which are
used as markers of lipid peroxidation. Lenses from the
Na2SeO3 group had increased levels of MDA (Fig. 3)
when compared to control group lenses, indicating
increased lipid peroxidation in the Na2SeO3 group. This
observation is consistent with other studies that reported
increased lipid peroxidation upon treatment with
Na2SeO3 [13, 14, 19, 23, 30, 60, 61]. NACA was able to
decrease the lipid peroxidation induced by Na2SeO3 by
providing adequate amounts of GSH, which is a
substrate for the glutathione peroxidase-catalyzed reduc-
tion of hydroperoxides.
A key GSH-dependent enzyme, Ttase, catalyzes the
conversion of protein disulfides back to protein thiols
using GSH as one of the substrates. During cataract
formation, oxidative stress builds up due to diminished
levels of GSH and leads to protein-thiol mixed disulfide
formation. Crystallin-thiol mixed disulfides then precipi-
tates within the lens causing the cataract [68]. We
speculate this may be due to decreased Ttase activity as
a consequence of lowered GSH levels during cataract
development. Depletion of Ttase activity in cataract
formation has been previously reported [45, 69, 70]. Rat
pups injected with Na2SeO3 showed decreased Ttase
enzyme activity, as compared to control, leading to the
precipitation of crystallin proteins, whereas treatment
with NACA restored the Ttase enzyme activity to a level
close to that of the control (Table 3).
Precipitation of proteins can also result from calcium
uptake in the lens. High concentrations of calcium in the
lens nucleus of selenite cataracts have been previously
Fig. 3 Effect of NACA on MDA levels in rat pups injected with Na2SeO3.
Lenses from sodium selenite injected rat pups showed significantly
higher levels of MDA compared to the control, whereas treatment with
NACA significantly decreased the MDA levels. Statistical Analysis was
performed by one-way analysis of variance, followed by Tukey’s multiple
comparison tests. *p < 0.05 compared to the control group and
#p < 0.05 compared to the Na2SeO3 group. Values are reported as
mean (n = 4) ± S.E




(GR mU/mg of protein)
Thioltransferase
(Ttase mU/mg of protein)
Control 0.77 ± 0.16 2.0 ± 0.28
NACA 0.92 ± 0.063 1.8 ± 0.20
Na2SeO3 1.3 ± 0.23
* 1.2 ± 0.19*
NACA + Na2SeO3 0.88 ± 0.16
# 1.8 ± 0.35
Activities of glutathione reductase and thioltransferase from the lenses of each
group. NACA treatment in the NACA + Na2SeO3 group significantly decreased
the glutathione reductase activity when compared to the glutathione reductase
activity of Na2SeO3 group lenses. Although NACA increased the thioltransferase
activity in NACA + Na2SeO3 group, it was not significantly higher when compared
to the Na2SeO3 group. Statistical analysis was performed by one-way analysis of
variance, followed by Tukey’s multiple comparison tests. *p < 0.05 compared to
the control group and #p < 0.05 compared to the Na2SeO3 group. Values are
reported as mean (n = 4) ± S.E.
Fig. 4 Effect of NACA on calcium levels in rat pups injected with
Na2SeO3. Lens from sodium selenite injected rat pups showed a
significantly higher calcium levels compared to the control, whereas
treatment with NACA significantly decreased the calcium levels.
Statistical Analysis was performed by one-way analysis of variance,
followed by Tukey’s multiple comparison tests. *p < 0.05 compared
to the control group and #p < 0.05 compared to the Na2SeO3 group.
Values are reported as mean (n = 4) ± S.E
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reported by Hightower [71] which may be due to in-
hibition of Ca-ATPase activity [72]. Accumulation of
calcium in the nucleus of the lens leads to m-calpain
activation, proteolysis, insolubilization, and precipita-
tion of crystallins. We have observed a 2.5-fold
increase in calcium levels in the lenses of the Na2SeO3
group, as compared to the levels in the control. Our
results are in agreement with other studies which previ-
ously reported elevated calcium levels in the lenses of
selenite-induced cataracts [21, 62, 71, 73]. Treatment of
selenite-challenged rats with NACA (NACA + Na2SeO3
group) prevented such an increase, and maintained the
lens calcium levels close to those of control (Fig. 4).
Calpains are cysteine proteases whose activity depends
on calcium concentrations. Based on the calcium levels
required to activate these calpains, two predominant forms
of calpains have been reported, μ-calpain (micromolar
concentrations of calcium) and m-calpain (millimolar
concentrations of calcium) [74]. Increased calcium levels
lead to dissociation of m-calpain subunits, resulting in acti-
vation of m-calpain, which hydrolyzes the lens substrates
such as crystallins leading to cataractogenesis. However, ac-
tivation of m-calpain is followed by degradative autolysis of
m-calpains [17]. In the present study, casein zymography
was performed to check m-calpain activation. Contrary to
our expectations based on increased calcium levels, lenses
from the Na2SeO3 group showed decreased m-calpain
activity with a less intense band (Fig. 5a). These re-
sults could be attributed to the degradative autolysis
of m-calpains subsequent to their activation. These
results were further supported by performing Western
blots of m-calpain. A similar trend with decreased
m-calpain levels were observed in the Na2SeO3 group
(Fig. 5b, c). Decreased m-calpain activity and levels
can thus be attributed to degradative autolysis follow-
ing activation of m-calpain [21, 71, 75, 76].
Several preliminary studies were done using this model




Fig. 5 Effect of NACA on a Casein zymography and b Western blot, and c Relative densitometry intensities of m-calpain. a Lens from sodium selenite
injected rat pups showed a decreased band intensity of m-calpain indicating decreased m-calpain activity compared to the control. However, treatment
with NACA preserved the m-calpain activity; b Western blot from sodium selenite injected rat pups showed a band intensity of m-calpain compared to
control; c Western blot results normalized to the levels of GAPDH gene. The graphs represent relative densitometric analysis of treated group lenses over
the control group lenses. Statistical Analysis was performed by one-way analysis of variance, followed by Tukey’s multiple comparison tests. *p < 0.05
compared to the control group and #p < 0.05 compared to the Na2SeO3 group. The graph is representative of triplicate gels and the values are reported
as mean ± S.E
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alone. However, we were limited due to this being an
acute model of cataract formation. In addition, the time-
sensitive and laborious nature of these experiments
resulted in the inclusion of fewer animals per treatment
group, being a further impediment.
Conclusion
In summary, our data indicate that oxidative stress plays
a role in cataract formation, particularly in glutathione
maintenance. For this reason, a GSH prodrug would be
effective as a therapeutic agent for prevention and rever-
sal of cataracts. The data support our hypothesis that
NACA protects by increasing GSH, reducing MDA
levels, restoring enzyme activities, and normalizing
calcium levels. Our future studies will focus on investi-
gating the effectiveness of NACA eye drops and its
pharmacokinetic profile in different animal models of
cataract formation.
Our present and future studies may eventually help
prevent cataract formation in high-risk populations and
treat early-stage cataracts without need for surgical inter-
vention. This would decrease the social and economic
burden of blindness worldwide.
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